Position in NTRA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$19,999
-$2,910 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $5,149,058 across 16 Diagnostics & Research names. NTRA ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,171 | $3,524,761 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
512 | $645,734 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,059 | $549,361 | |
| 4 | DHR |
Danaher Corp /De/
|
1,245 | $236,052 | |
| 5 | WAT |
Waters Corp /De/
|
334 | $99,465 | |
| 6 | DGX |
Quest Diagnostics Inc
|
187 | $36,648 | |
| 7 | NTRA |
Natera, Inc.
This page
|
100 | $19,999 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
658 | $9,133 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,999 | 100 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $22,909 | 100 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $13,455 | 85 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $17,773 | 140 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $15,160 | 140 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $12,804 | 140 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,888 | 94 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||